Cholet C, Delalandre C, Monnier-Cholley L, Le Pimpec-Barthes F, El Mouhadi S, Arrivé L. 499 Nontraumatic chylothorax: nonenhanced MR lymphography. Radiographics. 2020;40(6):1554–73.
Liu ME, Branstetter BF IV, Whetstone J, Escott EJ. Normal CT appearance of the distal thoracic 512 duct. Am J Roentgenol. 2006;187(6):1615–20.
Mauro MA, Murphy KPJ, Thomson KR, Venbrux AC, Morgan RA. Image-guided interventions 514 e-book: expert radiology series. Amsterdam: Elsevier Health Sciences; 2013.
Shields TW, Reed C, LoCicero J III, Feins R. General thoracic surgery. 7th ed. Philadelphia: 516 LWW; 2009.
Maldonado F, Cartin-Ceba R, Hawkins FJ, Ryu JH. Medical and surgical management of 518 chylothorax and associated outcomes. Am J Med Sci. 2010;339(4):314–8.
Phang K, Bowman M, Phillips A, Windsor J. Review of thoracic duct anatomical variations and 523 clinical implications. Clin Anatomy. 2014;27(4):637–44.
Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardio Thor Surg. 2007;32(2):362–9.
Wieseler B, McGauran N. Reporting a systematic review. Chest. 2010;137:1240–6.
McWilliams A, Gabbay E. Chylothorax occurring 23 years post-irradiation: literature review 529 and management strategies. Respirology. 2000;5(3):301–3.
Article CAS PubMed Google Scholar
Shah RD, Luketich JD, Schuchert MJ, Christie NA, Pennathur A, Landreneau RJ, et al. 502 Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg. 2012;93(3):897–904.
Article PubMed PubMed Central Google Scholar
McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med. 2010;104(1):1–8.
Huggins JT. Chylothorax and cholesterol pleural effusion. In: Seminars in respiratory and 538 critical care medicine. New York: Thieme Medical Publishers; 2010. p. 743–50.
Doerr CH, Allen MS, Nichols FC III, Ryu JH. Etiology of chylothorax in 203 patients. In: Mayo 527 Clinic Proceedings. Amsterdam: Elsevier; 2005. p. 867–70.
Davis SN, Clark F. Multiple myeloma as a cause of chylothorax. J R Soc Med. 1986;79(1):49.
Article CAS PubMed PubMed Central Google Scholar
Teng C, Li K, Yu J, Hsu S, Wang R, Hwang W. Malignancy-associated chylothorax: a 20-year 541 study of 18 patients from a single institution. Eur J Cancer Care (Engl). 2012;21(5):599–605.
O’callaghan AM, Mead GM. Chylothorax in lymphoma: mechanisms and management. The 543 teaching cases from annals of oncology. Cham: Springer; 1997. p. 63–7.
Servelle M, Nogues C, Soulie J, Andrieux JB, Terhedebrugge R. Spontaneous, post-operative 592 and traumatic chylothorax. J Cardiovasc Surg (Torino). 1980;21(4):475–86.
Light RW. Pleural diseases. Evidence-based. Respir Med. 1995;521–36:600.
Romero S. Nontraumatic chylothorax. Curr Opin Pulm Med. 2000;6(4):287–91.
Article CAS PubMed Google Scholar
Sassoon CS, Light RW. Chylothorax and pseudochylothorax. Clin Chest Med. 1985;6(1):163–497.
Article CAS PubMed Google Scholar
Agrawal V, Doelken P, Sahn SA. Pleural fluid analysis in chylous pleural effusion. Chest. 2008;133(6):1436–41.
De Beer HGJ, Mol MJT, Janssen JP. Chylothorax. Neth J Med. 2000;56(1):25–31.
Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K. The lipoprotein profile of 619 chylous and nonchylous pleural effusions. In: Mayo Clinic Proceedings. 1980. p. 700–4
Repp R, Scheld HH, Bauer J, Becker H, Kreuder J, Netz H. Cyclosporine losses by a chylothorax. J Heart Lung Transplant. 1992;11(2 Pt 1):397–8.
Merrigan BA, Winter DC, O’sullivan GC. Chylothorax. J Br Surg. 1997;84(1):15–622.
Majdalany BS, Murrey DA Jr, Kapoor BS, Cain TR, Ganguli S, Kent MS, et al. ACR 587 appropriateness criteria® chylothorax treatment planning. J Am Coll Radiol. 2017;14(5):S118–26.
Zhang C, Chen X, Wen T, Zhang Q, Huo M, Dong J, et al. Computed tomography 627 lymphangiography findings in 27 cases of lymphangioleiomyomatosis. Acta Radiol. 2017;58(11):1342–8.
Yoshida RY, Kariya S, Ha-Kawa S, Tanigawa N. Lymphoscintigraphy for imaging of the lymphatic 630 flow disorders. Tech Vasc Interv Radiol. 2016;19(4):273–6.
Rehman KU, Sivakumar P. Non-traumatic chylothorax: diagnostic and therapeutic strategies. Breathe. 2022;18(2):591.
Bender B, Murthy V, Chamberlain RS. The changing management of chylothorax in the modern 656 era. Eur J Cardio Thor Surg. 2016;49(1):18–24.
Duletzke NT, Kiraly LN, Martindale RG. Chylothorax and chylous ascites: Overview, 658 management, and nutrition. Nutr Clin Pract. 2023;38(3):557–63.
Bryant AS, Minnich DJ, Wei B, Cerfolio RJ. The incidence and management of postoperative 660 chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection. Ann Thorac Surg. 2014;98(1):232–7.
Power R, Smyth P, Donlon NE, Nugent T, Donohoe CL, Reynolds JV. Management of chyle leaks 663 following esophageal resection: a systematic review. Dis Esop. 2021;34(11):012.
Martucci N, Tracey M, Rocco G. Postoperative chylothorax. Thorac Surg Clin. 2015;25(4):523–666.
Iqbal MH, Smith PR, Bande S. Chylothorax due to angioimmunoblastic T-cell lymphoma. Intern Med J. 2009;39(1):67–8.
Article CAS PubMed Google Scholar
Sriram K, Meguid RA, Meguid MM. Nutritional support in adults with chyle leaks. Nutrition. 2016;32(2):281–6.
Alvarez JF, Kalache KD, Grauel EL. Management of spontaneous congenital chylothorax: oral 672 medium-chain triglycerides versus total parenteral nutrition. Am J Perinatol. 1999;16(08):415–20.
Takuwa T, Yoshida J, Ono S, Hishida T, Nishimura M, Aokage K, et al. Low-fat diet management 675 strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. J Thorac Cardiovasc Surg. 2013;146(3):571–4.
Smoke A, DeLegge MH. Chyle leaks: consensus on management? Nut Clin Prac. 2008;23(5):529–32.
Roehr CC, Jung A, Proquitté H, Blankenstein O, Hammer H, Lakhoo K, et al. Somatostatin or 682 octreotide as treatment options for chylothorax in young children: a systematic review. Intensive Care Med. 2006;32:650–7.
Article CAS PubMed Google Scholar
Evans J, Clark MF, Mincher L, Varney VA. Chylous effusions complicating lymphoma: a serious 685 event with octreotide as a treatment option. Hematol Oncol. 2003;21(2):77–81.
Article CAS PubMed Google Scholar
Hillerdal G. Yellow nail syndrome: treatment with octreotide. Clin Respir J. 2007;1(2):120–1.
留言 (0)